{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T02:12:49Z","timestamp":1791339169175,"version":"4.3.1"},"reference-count":120,"publisher":"Zhejiang University Press","issue":"1","license":[{"start":{"date-parts":[[2013,1,1]],"date-time":"2013-01-01T00:00:00Z","timestamp":1356998400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J. Zhejiang Univ. Sci. B"],"published-print":{"date-parts":[[2013,1]]},"DOI":"10.1631\/jzus.b1200189","type":"journal-article","created":{"date-parts":[[2013,1,9]],"date-time":"2013-01-09T16:05:52Z","timestamp":1357747552000},"page":"8-24","source":"Crossref","is-referenced-by-count":33,"title":["Epstein-Barr virus interactions with the Bcl-2 protein family and apoptosis in human tumor cells"],"prefix":"10.1631","volume":"14","author":[{"given":"Qin","family":"Fu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zheng-rong","family":"Mao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"635","published-online":{"date-parts":[[2013,1,10]]},"reference":[{"issue":"15","key":"3347_CR1","doi-asserted-by":"crossref","first-page":"2260","DOI":"10.1038\/sj.onc.1206402","volume":"22","author":"B. Abdulkarim","year":"2003","unstructured":"Abdulkarim, B., Sabri, S., Zelenika, D., Deutsch, E., Frascogna, V., Klijanienko, J., Vainchenker, W., Joab, I., Bourhis, J., 2003. Antiviral agent Cidofovir decreases Epstein-Barr virus (EBV) oncoproteins and enhances the radiosensitivity in EBV-related malignancies. Oncogene, 22(15):2260\u20132271. [doi:10.1038\/sj.onc.1206402]","journal-title":"Oncogene"},{"issue":"38","key":"3347_CR2","doi-asserted-by":"crossref","first-page":"14188","DOI":"10.1073\/pnas.0605985103","volume":"103","author":"M. Altmann","year":"2006","unstructured":"Altmann, M., Pich, D., Ruiss, R., Hammers Chmidt, W., Wang, J., Sugden, B., 2006. Transcriptional activation by EBV nuclear antigen 1 is essential for the expression of EBV\u2019s transforming genes. PNAS, 103(38):14188\u201314193. [doi:10.1073\/pnas.0605985103]","journal-title":"PNAS"},{"issue":"4","key":"3347_CR3","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1038\/sj.onc.1210668","volume":"27","author":"E. Anderton","year":"2008","unstructured":"Anderton, E., Yee, J., Smith, P., Crook, T., White, R.E., 2008. Two Epstein-Barr virus (EBV) oncoproteins cooperate to repress expression of the proapoptotic tumor-suppressor Bim: clues to the pathogenesis of Burkitt\u2019s lymphoma. Oncogene, 27(4):421\u2013433. [doi:10.1038\/sj.onc.1210668]","journal-title":"Oncogene"},{"issue":"5208","key":"3347_CR4","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1126\/science.7716513","volume":"268","author":"S. Artavanis-Tsakonas","year":"1995","unstructured":"Artavanis-Tsakonas, S., Matsuno, K., Fortini, M.E., 1995. Notch signaling. Science, 268(5208):225\u2013232. [doi:10.1126\/science.7716513]","journal-title":"Science"},{"issue":"1","key":"3347_CR5","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1002\/jcp.21567","volume":"218","author":"A.S. Azmi","year":"2009","unstructured":"Azmi, A.S., Mohammad, R.M., 2009. Non-peptidic small molecule inhibitors against Bcl-2 for cancer therapy. J. Cell. Physiol., 218(1):13\u201321. [doi:10.1002\/jcp.21567]","journal-title":"J. Cell. Physiol."},{"issue":"4","key":"3347_CR6","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S1074-7613(00)00049-2","volume":"13","author":"G.J. Babcock","year":"2000","unstructured":"Babcock, G.J., Hochberg, D., Thorley-Lawson, D.A., 2000. The expression pattern of Epstein-Barr virus latent genes in vivo is dependent upon the differentiation stage of the infected B cell. Immunity, 13(4):497\u2013506. [doi:10.1016\/S1074-7613(00)00049-2]","journal-title":"Immunity"},{"issue":"3","key":"3347_CR7","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1016\/S0092-8674(85)80070-2","volume":"41","author":"A. Bakhshi","year":"1985","unstructured":"Bakhshi, A., Jensen, J.P., Goldman, P., Wright, J.J., McBride, O.W., Epstein, A.L., Korsmeyer, S.J., 1985. Cloning the chromosomal breakpoint of the (14; 18) human lymphomas: clustering around JH on chromosome 14 and near atranscriptional unit on 18. Cell, 41(3):899\u2013906. [doi:10.1016\/S0092-8674(85)80070-2]","journal-title":"Cell"},{"issue":"1","key":"3347_CR8","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1172\/JCI11891","volume":"107","author":"A.S. Baldwin Jr.","year":"2001","unstructured":"Baldwin, A.S.Jr., 2001. Series introduction: the transcription factor NF-\u03baB and human disease. J. Clin. Invest., 107(1):3\u20136. [doi:10.1172\/JCI11891]","journal-title":"J. Clin. Invest."},{"issue":"2","key":"3347_CR9","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/mc.20156","volume":"45","author":"G. Bartholomeusz","year":"2006","unstructured":"Bartholomeusz, G., Wu, Y., Ali Seyed, M., Xia, W., Kwong, K.Y., Hortobagyi, G., Hung, M.C., 2006. Nuclear translocation of the pro-apoptotic Bcl-2 family member bok induces apoptosis. Mol. Carcinogen., 45(2):73\u201383. [doi:10.1002\/mc.20156]","journal-title":"Mol. Carcinogen."},{"issue":"5","key":"3347_CR10","doi-asserted-by":"crossref","first-page":"2469","DOI":"10.1128\/jvi.76.5.2469-2479.2002","volume":"76","author":"D.S. Bellows","year":"2002","unstructured":"Bellows, D.S., Howell, M., Pearson, C., Hazlewood, S.A., Hardwick, J.M., 2002. Epstein-Barr virus BALF1 is a BCL-2-like antagonist of the herpesvirus antiapoptotic BCL-2 proteins. J. Virol., 76(5):2469\u20132479. [doi:10.1128\/jvi.76.5.2469-2479.2002]","journal-title":"J. Virol."},{"issue":"42","key":"3347_CR11","doi-asserted-by":"crossref","first-page":"17945","DOI":"10.1073\/pnas.0907994106","volume":"106","author":"K.T. Bieging","year":"2009","unstructured":"Bieging, K.T., Amick, A.C., Longnecker, R., 2009. Epstein-Barr virus LMP2A bypasses p53 inactivation in a MYC model of lymphoma genesis. PNAS, 106(42):17945\u201317950. [doi:10.1073\/pnas.0907994106]","journal-title":"PNAS"},{"issue":"5","key":"3347_CR12","doi-asserted-by":"crossref","first-page":"901","DOI":"10.4161\/cc.9.5.10840","volume":"9","author":"K.T. Bieging","year":"2010","unstructured":"Bieging, K.T., Swanson-Mungerson, M., Amick, A.C., Longnecker, R., 2010. Epstein-Barr virus in Burkitt\u2019s lymphoma: a role for latent membrane protein 2A. Cell Cycle, 9(5):901\u2013908. [doi:10.4161\/cc.9.5.10840]","journal-title":"Cell Cycle"},{"issue":"1408","key":"3347_CR13","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1098\/rstb.2000.0781","volume":"356","author":"G.W. Bornkamm","year":"2001","unstructured":"Bornkamm, G.W., Hammerschmidt, W., 2001. Molecular virology of Epstein-Barr virus. Philosoph. Transact. Roy. Soc. B, 356(1408):437\u2013459. [doi:10.1098\/rstb.2000.0781]","journal-title":"Philosoph. Transact. Roy. Soc. B"},{"issue":"9","key":"3347_CR14","first-page":"1921","volume":"11","author":"J.M. Boyd","year":"1995","unstructured":"Boyd, J.M., Gallo, G.J., Elanqovan, B., Houqhton, B., Malstrom, S., Avery, B.J., Ebb, R.G., Subramanian, T., Chittenden, T., Lutz, R.J., 1995. Bik, a novel death-inducing protein shares a distinct sequence motif with Bcl-2 family proteins and interacts with viral and cellular survival-promoting proteins. Oncogene, 11(9):1921\u20131928.","journal-title":"Oncogene"},{"issue":"3","key":"3347_CR15","doi-asserted-by":"crossref","first-page":"e23","DOI":"10.1371\/journal.ppat.0020023","volume":"2","author":"X. Cai","year":"2006","unstructured":"Cai, X., Schafer, A., Lu, S., Bilello, J.P., Desrosiers, R.C., Edwards, R., Raab-Traub, N., Cullen, B.R., 2006. Epstein-Barr virus microRNAs are evolutionarily conserved and differentially expressed. PLoS Pathog., 2(3):e23. [doi:10.1371\/journal.ppat.0020023]","journal-title":"PLoS Pathog."},{"issue":"2","key":"3347_CR16","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1182\/blood.V86.2.432.bloodjournal862432","volume":"86","author":"B.S. Carmilleri-Broet","year":"1995","unstructured":"Carmilleri-Broet, B.S., Davi, F., Feuillard, J., Bourgeois, C., Seilhean, D., Hauw, J.J., Rapha\u00ebl, M., 1995. High expression of latent membrane protein 1 of Epstein-Barr virus and BCL-2 oncoprotein in acquired immunodeficiency syndrome-related primary brain lymphomas. Blood, 86(2):432\u2013435.","journal-title":"Blood"},{"issue":"11","key":"3347_CR17","doi-asserted-by":"crossref","first-page":"2551","DOI":"10.1084\/jem.20072581","volume":"205","author":"E.Y. Choy","year":"2008","unstructured":"Choy, E.Y., Siu, K.L., Kok, K.H., Lung, R.W., Tsang, C.M., To, K.F., Kwong, D.L., Tsao, S.W., Jin, D.Y., 2008. An Epstein-Barr virus-encoded microRNA targets PUMA to promote host cell survival. J. Exp. Med., 205(11): 2551\u20132560. [doi:10.1084\/jem.20072581]","journal-title":"J. Exp. Med."},{"issue":"5","key":"3347_CR18","doi-asserted-by":"crossref","first-page":"2968","DOI":"10.4049\/jimmunol.175.5.2968","volume":"175","author":"C. Clybouw","year":"2005","unstructured":"Clybouw, C., McHichi, B., Mouhamad, S., Auffredou, M.T., Bourgeade, M.F., Sharma, S., Leca, G., Vazquez, A., 2005. EBV infection of human B lymphocytes leads to down-regulation of Bim expression: relationship to resistance to apoptosis. J. Immunol., 175(5):2968\u20132973.","journal-title":"J. Immunol."},{"issue":"9","key":"3347_CR19","doi-asserted-by":"crossref","first-page":"7627","DOI":"10.1128\/JVI.73.9.7627-7632.1999","volume":"73","author":"J.I. Cohen","year":"1999","unstructured":"Cohen, J.I., Lekstrom, K., 1999. Epstein-Barr virus BARF1 protein is dispensable for B-cell transformation and inhibits alpha interferon secretion from mononuclear cells. J. Virol., 73(9):7627\u20137632.","journal-title":"J. Virol."},{"issue":"53","key":"3347_CR20","doi-asserted-by":"crossref","first-page":"8590","DOI":"10.1038\/sj.onc.1207102","volume":"22","author":"S. Cory","year":"2003","unstructured":"Cory, S., Huang, D.C., Adams, J.M., 2003. The Bcl-2 family: roles in cell survival and oncogenesis. Oncogene, 22(53):8590\u20138607. [doi:10.1038\/sj.onc.1207102]","journal-title":"Oncogene"},{"issue":"12","key":"3347_CR21","doi-asserted-by":"crossref","first-page":"4085","DOI":"10.1073\/pnas.82.12.4085","volume":"82","author":"J. Countryman","year":"1985","unstructured":"Countryman, J., Miller, G., 1985. Activation of expression of latent Epstein-Barr herpesvirus after gene transfer with a small cloned subfragment of heterogeneous viral DNA. PNAS, 82(12):4085\u20134089. [doi:10.1073\/pnas.82.12.4085]","journal-title":"PNAS"},{"issue":"6","key":"3347_CR22","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1038\/cdd.2008.14","volume":"15","author":"J.R. Cross","year":"2008","unstructured":"Cross, J.R., Postigo, A., Blight, K., Downward, J., 2008. Viral pro-survival proteins block separate stages in Bax activation but changes in mitochondrial ultrastructure still occur. Cell Death Differ., 15(6):997\u20131008. [doi:10.1038\/cdd.2008.14]","journal-title":"Cell Death Differ."},{"issue":"2","key":"3347_CR23","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/S0092-8674(04)00046-7","volume":"116","author":"N.N. Danial","year":"2004","unstructured":"Danial, N.N., Korsmeyer, S.J., 2004. Cell death: critical control points. Cell, 116(2):205\u2013219. [doi:10.1016\/S0092-8674(04)00046-7]","journal-title":"Cell"},{"issue":"2","key":"3347_CR24","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.canlet.2011.02.007","volume":"305","author":"S.R. Silva da","year":"2011","unstructured":"da Silva, S.R., de Oliveira, D.E., 2011. HIV, EBV and KSHV: viral cooperation in the pathogenesis of human malignancies. Cancer Lett., 305(2):175\u2013185. [doi:10.1016\/j.canlet.2011.02.007]","journal-title":"Cancer Lett."},{"issue":"11","key":"3347_CR25","doi-asserted-by":"crossref","first-page":"9016","DOI":"10.1128\/JVI.72.11.9016-9024.1998","volume":"72","author":"C.W. Dawson","year":"1998","unstructured":"Dawson, C.W., Dawson, J., Jones, R., Ward, K., Young, L.S., 1998. Functional differences between BHRF1, the EBV-encoded Bcl-2 homologue, and bcl-2 in human epithelial cells. J. Virol., 72(11):9016\u20139024.","journal-title":"J. Virol."},{"issue":"14","key":"3347_CR26","doi-asserted-by":"crossref","first-page":"5663","DOI":"10.1073\/pnas.0901036106","volume":"106","author":"A.L. Desbien","year":"2009","unstructured":"Desbien, A.L., Kappler, J.W., Marrack, P., 2009. The Epstein-Barr virus Bcl-2 homolog, BHRF1, blocks apoptosis by binding to a limited amount of Bim. PNAS, 106(14): 5663\u20135668. [doi:10.1073\/pnas.0901036106]","journal-title":"PNAS"},{"issue":"12","key":"3347_CR27","doi-asserted-by":"crossref","first-page":"3080","DOI":"10.1093\/emboj\/19.12.3080","volume":"19","author":"R. Feederle","year":"2000","unstructured":"Feederle, R., Kost, M., Baumann, M., Janz, A., Drouet, E., Hammerschmidt, W., Delecluse, H.J., 2000. The Epstein-Barr virus lytic program is controlled by the co-operative functions of two transactivators. EMBO J., 19(12):3080\u20133089. [doi:10.1093\/emboj\/19.12.3080]","journal-title":"EMBO J."},{"issue":"2","key":"3347_CR28","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1182\/blood.V80.2.459.459","volume":"80","author":"J. Finke","year":"1992","unstructured":"Finke, J., Fritzen, R., Ternes, P., Trivedi, P., Bross, K.J., Lange, W., Mertelsmann, R., Dolken, G., 1992. Expression of bcl-2 in Burkitt\u2019s lymphoma cell lines: induction by latent Epstein-Barr virus genes. Blood, 80(2):459\u2013469.","journal-title":"Blood"},{"issue":"3","key":"3347_CR29","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1038\/sj.cdd.4402292","volume":"15","author":"A.M. Flanagan","year":"2008","unstructured":"Flanagan, A.M., Letai, A., 2008. BH3 domains define selective inhibitory interactions with BHRF-1 and KSHV BCL-2. Cell Death Differ., 15(3):580\u2013588. [doi:10.1038\/sj.cdd.4402292]","journal-title":"Cell Death Differ."},{"issue":"14\u201315","key":"3347_CR30","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1016\/j.micinf.2011.07.007","volume":"13","author":"E. Forte","year":"2011","unstructured":"Forte, E., Luftig, M.A., 2011. The role of microRNAs in Epstein-Barr virus latency and lytic reactivation. Microbes Infect., 13(14\u201315):1156\u20131167. [doi:10.1016\/j.micinf.2011.07.007]","journal-title":"Microbes Infect."},{"issue":"2012","key":"3347_CR31","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2012\/509296","volume":"2012","author":"S.K. Ghosh","year":"2012","unstructured":"Ghosh, S.K., Perrine, S.P., Faller, D.V., 2012. Advances in virus-directed therapeutics against Epstein-Barr virus-associated malignancies. Adv. Virol., 2012(2012):1\u201311. [doi:10.1155\/2012\/509296]","journal-title":"Adv. Virol."},{"issue":"5","key":"3347_CR32","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1261\/rna.2326106","volume":"12","author":"A. Grundhoff","year":"2006","unstructured":"Grundhoff, A., Sullivan, C.S., Ganem, D., 2006. A combined computational and microarray-based approach identifies novel microRNAs encoded by human gamma-herpesviruses. RNA, 12(5):733\u2013750. [doi:10.1261\/rna.2326106]","journal-title":"RNA"},{"issue":"2","key":"3347_CR33","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1136\/mp.52.2.97","volume":"52","author":"D.P. Hayes","year":"1999","unstructured":"Hayes, D.P., Brink, A.A.T., Vervoort, M.B.H.J., Brule, A.J., Middeldorp, J.M., Meijer, C.J.L., 1999. Expression of Epstein-Barr virus (EBV) transcripts encoding homologues to important human proteins in diverse EBV associated diseases. J. Clin. Pathol. Mol., 52(2):97\u2013103. [doi:10.1136\/mp.52.2.97]","journal-title":"J. Clin. Pathol. Mol."},{"issue":"5","key":"3347_CR34","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.semcancer.2004.04.018","volume":"14","author":"S.D. Hayward","year":"2004","unstructured":"Hayward, S.D., 2004. Viral interactions with the Notch pathway. Semin. Cancer Biol., 14(5):387\u2013396. [doi:10.1016\/j.semcancer.2004.04.018]","journal-title":"Semin. Cancer Biol."},{"issue":"18","key":"3347_CR35","doi-asserted-by":"crossref","first-page":"8479","DOI":"10.1073\/pnas.90.18.8479","volume":"90","author":"S. Henderson","year":"1993","unstructured":"Henderson, S., Huen, D., Rowe, M., Dawson, C., Johnson, G., Rickinson, A., 1993. Epstein-Barr virus-coded BHRF1 protein, a viral homologue of Bcl-2, protects human B cells from programmed cell death. PNAS, 90(18):8479\u20138483. [doi:10.1073\/pnas.90.18.8479]","journal-title":"PNAS"},{"key":"3347_CR36","first-page":"2808","volume":"54","author":"T. Hickish","year":"1994","unstructured":"Hickish, T., Robertson, D., Clarke, P., Hill, M., Stefano, F., Clarke, C., Cunningham, D., 1994. Ultrastructural localization of BHRF1: an Epstein-Barr virus gene product which has homology with bcl-2. Cancer Res., 54:2808\u20132811.","journal-title":"Cancer Res."},{"issue":"6","key":"3347_CR37","first-page":"1","volume":"5","author":"M. Howell","year":"2005","unstructured":"Howell, M., Williams, T., Hazlewood, S.A., 2005. Herpesvirus pan encodes a functional homologue of BHRF1, the Epstein-Barr virus v-Bcl-2. BMC Microbiol., 5(6):1\u201311. [doi:10.1186\/1471-2180-5-6]","journal-title":"BMC Microbiol."},{"issue":"9","key":"3347_CR38","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1210\/me.12.9.1432","volume":"12","author":"S.Y. Hsu","year":"1998","unstructured":"Hsu, S.Y., Lin, P., Hsueh, A.J.W., 1998. BOD (bcl-2-related ovarian death gene) is an ovarian BH3 domain-containing proapoptotic bcl-2 protein capable of dimerization with diverse antiapoptotic bcl-2 members. Mol. Endocrinol., 12(9):1432\u20131440. [doi:10.1210\/me.12.9.1432]","journal-title":"Mol. Endocrinol."},{"issue":"12","key":"3347_CR39","doi-asserted-by":"crossref","first-page":"1858","DOI":"10.1210\/me.11.12.1858","volume":"11","author":"S.Y. Hsu","year":"1997","unstructured":"Hsu, S.Y., Kaipia, A., Zhu, L., Hsueh, A.J.W., 1997. Interference of BAD (Bcl-xL\/Bcl-2-associated death promoter)-induced apoptosis in mammalian cells by 14-3-3 isoforms and P11. Mol. Endocrinol., 11(12):1858\u20131867. [doi:10.1210\/me.11.12.1858]","journal-title":"Mol. Endocrinol."},{"issue":"6","key":"3347_CR40","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1016\/S0092-8674(00)00187-2","volume":"103","author":"D.C.S. Huang","year":"2000","unstructured":"Huang, D.C.S., Strasser, A., 2000. BH3-only proteins-essential initiators of apoptotic cell death. Cell, 103(6):839\u2013842. [doi:10.1016\/S0092-8674(00)00187-2]","journal-title":"Cell"},{"key":"3347_CR41","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1038\/ng1089","volume":"33","author":"R. Jaenisch","year":"2003","unstructured":"Jaenisch, R., Bird, A., 2003. Epigenetic regulation of gene expression: how the genome integrates intrinsic and environmental signals. Nat. Genet., 33:245\u2013254. [doi:10.1038\/ng1089]","journal-title":"Nat. Genet."},{"issue":"3","key":"3347_CR42","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1042\/BJ20041596","volume":"387","author":"S. Jamil","year":"2005","unstructured":"Jamil, S., Sobouti, R., Hojabrpour, P., Raj, M., Kast, J., Duronio, V., 2005. A proteolytic fragment of Mcl-1 exhibits nuclear localization and regulates cell growth by interaction with Cdk1. Biochem. J., 387(3):659\u2013667. [doi:10.1042\/BJ20041596]","journal-title":"Biochem. J."},{"issue":"9243","key":"3347_CR43","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.1016\/S0140-6736(00)03207-4","volume":"356","author":"B. Jansen","year":"2000","unstructured":"Jansen, B., Wachek, V., Heere-Ress, E., Schlagbauer-Wadl, H., Hoeller, C., Lucas, T., Hoermann, M., Hollenstein, U., Wolff, K., Pehamberger, H., 2000. Chemosensitization of malignant melanoma by BCL-2 antisense therapy. Lancet, 356(9243):1728\u20131733. [doi:10.1016\/S0140-6736(00)03 207-4]","journal-title":"Lancet"},{"issue":"1","key":"3347_CR44","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.ejcb.2011.01.014","volume":"91","author":"M. Kalla","year":"2012","unstructured":"Kalla, M., Hammerschmidt, W., 2012. Human B cells on their route to latent infection-early but transient expression of lytic genes of Epstein-Barr virus. Eur. J. Cell Biol., 91(1):65\u201369. [doi:10.1016\/j.ejcb.2011.01.014]","journal-title":"Eur. J. Cell Biol."},{"issue":"2","key":"3347_CR45","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1073\/pnas.0911948107","volume":"107","author":"M. Kalla","year":"2010","unstructured":"Kalla, M., Schmeinck, A., Bergbauer, M., Pich, D., Hammerschmidt, W., 2010. AP-1 homolog BZLF1 of Epstein-Barr virus has two essential functions dependent on the epigenetic state of the viral genome. PNAS, 107(2):850\u2013855. [doi:10.1073\/pnas.0911948107]","journal-title":"PNAS"},{"issue":"3","key":"3347_CR46","doi-asserted-by":"crossref","first-page":"e1000341","DOI":"10.1371\/journal.ppat.1000341","volume":"5","author":"G.L. Kelly","year":"2009","unstructured":"Kelly, G.L., Long, H.M., Stylianou, J., Thomas, W.A., Leese, A., Bell, A.I., Bornkamm, G.W., Autner, J.M., Rickinson, A.B., Rowe, M., 2009. An Epstein-Barr virus anti-apoptotic protein constitutively expressed in transformed cells and implicated in Burkitt\u2019s lymphomagenesis: the WP\/BHRF1 link. PLoS Pathog., 5(3):e1000341. [doi:10.1371\/journal.ppat.1000341]","journal-title":"PLoS Pathog."},{"issue":"24","key":"3347_CR47","doi-asserted-by":"crossref","first-page":"14269","DOI":"10.1073\/pnas.2336099100","volume":"100","author":"G. Kennedy","year":"2003","unstructured":"Kennedy, G., Komano, J., Sugden, B., 2003. Epstein-Barr virus provides a survival factor to Burkitt\u2019s lymphomas. PNAS, 100(24):14269\u201314274. [doi:10.1073\/pnas.2336099100]","journal-title":"PNAS"},{"issue":"5","key":"3347_CR48","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1182\/blood.V92.5.1721","volume":"92","author":"J.L. Kenney","year":"1998","unstructured":"Kenney, J.L., Guinness, M.E., Curiel, T., Lacy, J., 1998. Antisense to the Epstein-Barr virus (EBV)-encoded latent membrane protein 1 (LMP-1) suppresses LMP-1 and bcl-2 expression and promotes apoptosis in EBV-immortalized B cells. Blood, 92(5):1721\u20131727.","journal-title":"Blood"},{"issue":"8","key":"3347_CR49","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.3109\/10428194.2012.659736","volume":"53","author":"J.H. Kim","year":"2012","unstructured":"Kim, J.H., Kim, W.S., Park, C., 2012. Epstein-Barr virus latent membrane protein-1 protects B-cell lymphoma from rituximab-induced apoptosis through miR-155-mediated Akt activation and up-regulation of Mcl-1. Leuk. Lymphoma, 53(8):1586\u20131591. [doi:10.3109\/10428194.2012.659736]","journal-title":"Leuk. Lymphoma"},{"issue":"3","key":"3347_CR50","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1111\/j.0309-0167.2004.01829.x","volume":"44","author":"L.H. Kim","year":"2004","unstructured":"Kim, L.H., Nadarajah, V.S., Peh, S.C., Poppema, S., 2004. Expression of Bcl-2 family members and presence of Epstein-Barr virus inthe regulation of cell growth and death in classical Hodgkin\u2019s lymphoma. Histopathology, 44(3):257\u2013267. [doi:10.1111\/j.0309-0167.2004.01829.x]","journal-title":"Histopathology"},{"key":"3347_CR51","first-page":"2492","volume":"6","author":"R.J. Klasa","year":"2000","unstructured":"Klasa, R.J., Bally, M.B., Ng, R., Goldie, J.H., Gascoyne, R.D., Wong, F.M.P., 2000. Eradication of human non-Hodgkin\u2019s lymphoma in SCID mice by BCL-2 antisense oligonucleotides combined with lowdose cyclophosphamide. Clin. Cancer Res., 6:2492\u20132500.","journal-title":"Clin. Cancer Res."},{"issue":"22","key":"3347_CR52","doi-asserted-by":"crossref","first-page":"5506","DOI":"10.1182\/blood-2008-11-190090","volume":"113","author":"H. Kohlhof","year":"2009","unstructured":"Kohlhof, H., Hampel, F., Hoffmann, R., Burtscher, H., Weidle, U.H., H\u00f6lzel, M., Eick, D., Zimber-Strobl, U., Strobl, L.J., 2009. Notch1, Notch2, and Epstein-Barr virus-encoded nuclear antigen 2 signaling differentially affects proliferation and survival of Epstein-Barr virus-infected B cells. Blood, 113(22):5506\u20135515. [doi:10.1182\/blood-2008-11-190090]","journal-title":"Blood"},{"issue":"11","key":"3347_CR53","doi-asserted-by":"crossref","first-page":"9150","DOI":"10.1128\/JVI.72.11.9150-9156.1998","volume":"72","author":"J. Komano","year":"1998","unstructured":"Komano, J., Sugiura, M., Takada, K., 1998. Epstein-Barr virus contributes to the malignant phenotype and to apoptosis resistance in Burkitt\u2019s lymphoma cell line Akata. J. Virol., 72(11):9150\u20139156.","journal-title":"J. Virol."},{"issue":"12","key":"3347_CR54","doi-asserted-by":"crossref","first-page":"9827","DOI":"10.1128\/JVI.73.12.9827-9831.1999","volume":"73","author":"J. Komano","year":"1999","unstructured":"Komano, J., Maruo, S., Kurozumi, K., Oda, T., Takada, K., 1999. Oncogenic role of Epstein-Barr virus-encoded RNAs in Burkitt\u2019s lymphoma cell line akata. J. Virol., 73(12):9827.","journal-title":"J. Virol."},{"issue":"8","key":"3347_CR55","doi-asserted-by":"crossref","first-page":"3516","DOI":"10.1073\/pnas.90.8.3516","volume":"90","author":"K.M. Kozopas","year":"1993","unstructured":"Kozopas, K.M., Yang, T., Buchan, H.L., Zhou, P., Craig, R.W., 1993. MCL1, a gene expressed in programmed myeloid cell differentiation, has sequence similarity to BCL2. PNAS, 90(8):3516\u20133520. [doi:10.1073\/pnas.90.8.3516]","journal-title":"PNAS"},{"issue":"12","key":"3347_CR56","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.ppat.1001236","volume":"6","author":"M. Kvansakul","year":"2010","unstructured":"Kvansakul, M., Wei, A.H., Fletcher, J.I., Willis, S.N., Chen, L., 2010. Structural basis for apoptosis inhibition by Epstein-Barr virus BHRF1. PLoS Pathog., 6(12):1\u201310. [doi:10.1371\/journal.ppat.1001236]","journal-title":"PLoS Pathog."},{"issue":"13","key":"3347_CR57","doi-asserted-by":"crossref","first-page":"4303","DOI":"10.1182\/blood-2007-04-087486","volume":"110","author":"F. Lantner","year":"2007","unstructured":"Lantner, F., Starlets, D., Gore, Y., Flaishon, L., Yamit, H.A., Dikstein, R., Leng, L., Bucala, R., Machluf, Y., Oren, M., et al., 2007. CD74 induces TAp63 expression leading to B-cell survival. Blood, 110(13):4303\u20134311. [doi:10.1182\/blood-2007-04-087486]","journal-title":"Blood"},{"key":"3347_CR58","doi-asserted-by":"crossref","first-page":"e18","DOI":"10.1017\/S1462399410001493","volume":"12","author":"B. Leber","year":"2010","unstructured":"Leber, B., Geng, F., Kale, J., Andrews, D.W., 2010. Drugs targeting Bcl2 family members as an emerging strategy in cancer. Exp. Rev. Mol. Med., 12:e18. [doi:10.1017\/S1462399410001572]","journal-title":"Exp. Rev. Mol. Med."},{"key":"3347_CR59","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1146\/annurev.pathol.4.110807.092222","volume":"4","author":"Y.S. Lee","year":"2009","unstructured":"Lee, Y.S., Dutta, A., 2009. MicroRNAs in cancer. Ann. Rev. Pathol., 4:199\u2013227. [doi:10.1146\/annurev.pathol.4.110807.092222]","journal-title":"Ann. Rev. Pathol."},{"issue":"3","key":"3347_CR60","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/S1535-6108(02)00127-7","volume":"2","author":"A. Letai","year":"2002","unstructured":"Letai, A., Bassik, M.C., Walensky, L.D., Sorcinelli, M.D., Weiler, S., Korsmeyer, S.J., 2002. Distinct BH3 domains either sensitize or activate mitochondrial apoptosis, serving as prototype cancer therapeutics. Cancer Cell, 2(3):183\u2013192. [doi:10.1016\/S1535-6108(02)00127-7]","journal-title":"Cancer Cell"},{"issue":"29","key":"3347_CR61","doi-asserted-by":"crossref","first-page":"27354","DOI":"10.1074\/jbc.M103821200","volume":"276","author":"L.Y. Li","year":"2001","unstructured":"Li, L.Y., Shih, H.M., Liu, M.Y., Chen, J.Y., 2001. The cellular protein PRA1 modulates the anti-apoptotic activity of Epstein-Barr virus BHRF1, a homologue of Bcl-2, through direct interaction. J. Biol. Chem., 276(29): 27354\u201327362. [doi:10.1074\/jbc.M103821200]","journal-title":"J. Biol. Chem."},{"issue":"14","key":"3347_CR62","doi-asserted-by":"crossref","first-page":"2531","DOI":"10.1038\/sj.onc.1207375","volume":"23","author":"M.T. Liu","year":"2004","unstructured":"Liu, M.T., Chen, Y,R., Chen, S.C., Hu, C.Y., Lin, C.S., Chang, Y.T., Wang, W.B., Chen, J.Y., 2004. Epstein-Barr virus latent membrane protein 1 induces micronucleus formation, represses DNA repair and enhances sensitivity to DNA-damaging agents in human epithelial cells. Oncogene, 23(14):2531\u20132539. [doi:10.1038\/sj.onc.1207375]","journal-title":"Oncogene"},{"issue":"16","key":"3347_CR63","doi-asserted-by":"crossref","first-page":"2635","DOI":"10.1038\/sj.onc.1208319","volume":"24","author":"M.T. Liu","year":"2005","unstructured":"Liu, M.T., Chang, Y.T., Chen, S.C., Chuang, Y.C., Chen, Y.R., Lin, C.S., Chen, J.Y., 2005. Epstein-Barr virus latent membrane protein 1 represses p53-mediated DNA repair and transcriptional activity. Oncogene, 24(16):2635\u20132646. [doi:10.1038\/sj.onc.1208319]","journal-title":"Oncogene"},{"issue":"5","key":"3347_CR64","first-page":"1931","volume":"9","author":"R. Loomis","year":"2003","unstructured":"Loomis, R., Carbone, R., Reiss, M., Lacy, J., 2003. Bcl-2 antisense (G3139, Genasense) enhances the in vitro and in vivo response of Epstein-Barr virus-associated lymphoproliferative disease to rituximab. Clin. Cancer Res., 9(5):1931\u20131939.","journal-title":"Clin. Cancer Res."},{"issue":"11","key":"3347_CR65","doi-asserted-by":"crossref","first-page":"2975","DOI":"10.1099\/0022-1317-78-11-2975","volume":"78","author":"J.Y. Lu","year":"1997","unstructured":"Lu, J.Y., Chen, J.Y., Hsu, T.Y., Yu, C.Y., Su, I.J., Yang, C.S., 1997. Cooperative interaction between Bcl-2 and Epstein-Barr virus latent membrane protein 1 in the growth transformation of human epithelial cells. J. Gen. Virol., 78(11):2975\u20132985.","journal-title":"J. Gen. Virol."},{"issue":"11","key":"3347_CR66","doi-asserted-by":"crossref","first-page":"5991","DOI":"10.1128\/JVI.65.11.5991-6000.1991","volume":"65","author":"A. Marchini","year":"1991","unstructured":"Marchini, A., Tomkinson, B., Cohen, J.I., Kieff, E., 1991. BHRF1, the Epstein-Barr virus gene with homology to Bcl2, is dispensable for B-lymphocyte transformation and virus replication. J. Virol., 65(11):5991\u20136000.","journal-title":"J. Virol."},{"issue":"2","key":"3347_CR67","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1006\/excr.1995.1083","volume":"217","author":"M.C. Marin","year":"1995","unstructured":"Marin, M.C., Hsu, B., Stephens, L.C., Brisbay, S., McDonnell, T.J., 1995. The functional basis of c-myc and bcl-2 complementation during multistep lymphomagenesis in vivo. Exp. Cell Res., 217(2):240\u2013247. [doi:10.1006\/excr.1995.1083]","journal-title":"Exp. Cell Res."},{"issue":"6","key":"3347_CR68","doi-asserted-by":"crossref","first-page":"5181","DOI":"10.1128\/JVI.73.6.5181-5185.1999","volume":"73","author":"W.L. Marshall","year":"1999","unstructured":"Marshall, W.L., Yim, C., Gustafson, E., Graf, T., Sage, D.R., Hanify, K., Williams, L., Fingeroth, J., Finberg, R.W., 1999. Epstein-Barr virus encodes a novel homolog of the bcl-2 oncogene that inhibits apoptosis and associates with Bax and Bak. J. Virol., 73(6):5181\u20135185.","journal-title":"J. Virol."},{"issue":"6","key":"3347_CR69","doi-asserted-by":"crossref","first-page":"2345","DOI":"10.1073\/pnas.94.6.2345","volume":"94","author":"M.E. McCurrach","year":"1997","unstructured":"McCurrach, M.E., Connor, T.M., Knudson, C.M., Korsmeyer, S.J., Lowe, S.W., 1997. Bax-deficiency promotes drug resistance and oncogenic transformation by attenuating p53-dependent apoptosis. PNAS, 94(6):2345\u20132349. [doi:10.1073\/pnas.94.6.2345]","journal-title":"PNAS"},{"issue":"1","key":"3347_CR70","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1093\/jnci\/92.1.34","volume":"92","author":"H. Miayake","year":"2000","unstructured":"Miayake, H., Tolcher, A., Gleave, M.E., 2000. Chemosensitization and delayed androgen-independent recurrence of prostate cancer with the use of antisense Bcl-2 oligodeoxynucleotides. J. Nat. Cancer Inst., 92(1):34\u201341. [doi:10.1093\/jnci\/92.1.34]","journal-title":"J. Nat. Cancer Inst."},{"key":"3347_CR71","first-page":"679","volume":"8","author":"M.J. Morris","year":"2002","unstructured":"Morris, M.J., Tong, W.P., Cordon-Cardo, C., Drobnjak, M., Kelly, W.K., Slovin, S.F., Terry, K.L., Siedlecki, K., Swanson, P., Rafi, M., et al., 2002. Phase I trial of BCL-2 antisense oligonucleotide (G3139) administered by continuous intravenous infusion in patients with advanced cancer. Clin. Cancer Res., 8:679\u2013683.","journal-title":"Clin. Cancer Res."},{"issue":"3","key":"3347_CR72","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/S1097-2765(01)00214-3","volume":"7","author":"K. Nakano","year":"2001","unstructured":"Nakano, K., Vousden, K.H., 2001. PUMA, a novel proapoptotic gene, is induced by p53. Mol. Cell, 7(3):683\u2013694. [doi:10.1016\/S1097-2765(01)00214-3]","journal-title":"Mol. Cell"},{"issue":"49","key":"3347_CR73","doi-asserted-by":"crossref","first-page":"19512","DOI":"10.1073\/pnas.0709443104","volume":"104","author":"M. Nguyen","year":"2007","unstructured":"Nguyen, M., Marcellus, R.C., Roulston, A., Watson, M., Serfass, L., Madiraju, S.R.M., Goulet, D., Viallet, J., B\u00e9lec, L., Billot, X., et al., 2007. Small molecule obatoclax (GX15-070) antagonizes MCL-1 and overcomes MCL-1-mediated resistance to apoptosis. PNAS, 104(49):19512\u201319517. [doi:10.1073\/pnas.0709443104]","journal-title":"PNAS"},{"issue":"1","key":"3347_CR74","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1046\/j.1365-2141.2001.02887.x","volume":"114","author":"T. Noguchi","year":"2001","unstructured":"Noguchi, T., Ikeda, K., Yamamoto, K., Yoshida, I., Ashiba, A., Tsuchiyama, J., Shinagawa, K., Yoshino, T., Takata, M., Harada, M., 2001. Antisense oligodeoxynucleotides to latent membrane protein 1 induce growth inhibition, apoptosis and Bcl-2 suppression in Epstein-Barr virus EBV-transformed B-lymphoblastoid cells, but not in EBV-positive natural killer cell lymphoma cells. Br. J. Haematol., 114(1):84\u201392. [doi:10.1046\/j.1365-2141.2001.02887.x]","journal-title":"Br. J. Haematol."},{"issue":"6","key":"3347_CR75","doi-asserted-by":"crossref","first-page":"e1000492","DOI":"10.1371\/journal.ppat.1000492","volume":"5","author":"K. Paschos","year":"2009","unstructured":"Paschos, K., Smith, P., Anderton, E., Middeldorp, J.M., White, R.E., Allday, M.J., 2009. Epstein-Barr virus latency in B cells leads to epigenetic repression and CpG methylation of the tumor suppressor gene bim. PLoS Pathogens., 5(6):e1000492. [doi:10.1371\/journal.ppat.1000492]","journal-title":"PLoS Pathogens."},{"issue":"15","key":"3347_CR76","doi-asserted-by":"crossref","first-page":"7233","DOI":"10.1093\/nar\/gks391","volume":"40","author":"K. Paschos","year":"2012","unstructured":"Paschos, K., Parker, G.A., Watanatanasup, E., White, R.E., Allday, M.J., 2012. BIM promoter directly targeted by EBNA3C in polycomb-mediated repression by EBV. Nucleic Acids Res., 40(15):7233\u20137246. [doi:10.1093\/nar\/gks391]","journal-title":"Nucleic Acids Res."},{"issue":"16","key":"3347_CR77","doi-asserted-by":"crossref","first-page":"8133","DOI":"10.1128\/JVI.00278-06","volume":"80","author":"P.M. Pegman","year":"2006","unstructured":"Pegman, P.M., Smith, S.M., D\u2019souza, B.N., Loughran, S.T., Maier, S., Kempkes, B., Cahill, P.A., G\u00e9linas, C., Simmons, M.J., Walls, D., 2006. Epstein-Barr virus nuclear antigen 2 trans-activates the cellular anti-apoptotic bfl-1 gene by a CBF1\/RBPJk-dependent pathway. J. Virol., 80(16):8133\u20138144. [doi:10.1128\/JVI.00278-06]","journal-title":"J. Virol."},{"issue":"5671","key":"3347_CR78","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1126\/science.1096781","volume":"304","author":"S. Pfeffer","year":"2004","unstructured":"Pfeffer, S., Zavolan, M., Grasser, F.A., Chien, M., Russo, J.J., Ju, J., John, B., Enright, J., Marks, D., Sander, C., et al., 2004. Identification of virus-encoded microRNAs. Science, 304(5671):734\u2013736. [doi:10.1126\/science.1096781]","journal-title":"Science"},{"issue":"53","key":"3347_CR79","doi-asserted-by":"crossref","first-page":"8619","DOI":"10.1038\/sj.onc.1207905","volume":"23","author":"T. Portis","year":"2004","unstructured":"Portis, T., Longnecker, R., 2004. Epstein-Barr virus (EBV) LMP2A mediates B-lymphocyte survival through constitutive activation of the Ras\/PI3K\/AKT pathway. Oncogene, 23(53):8619\u20138628. [doi:10.1038\/sj.onc.1207905]","journal-title":"Oncogene"},{"issue":"8","key":"3347_CR80","doi-asserted-by":"crossref","first-page":"4380","DOI":"10.1128\/JVI.06966-11","volume":"86","author":"Z.L. Pratt","year":"2012","unstructured":"Pratt, Z.L., Zhang, J., Sugden, B., 2012. Simultaneously induce and inhibit oncogene of Epstein-Barr virus can the latent membrane protein 1 (LMP1) apoptosis in B cells. J. Virol., 86(8):4380. [doi:10.1128\/JVI.06966-11]","journal-title":"J. Virol."},{"issue":"7","key":"3347_CR81","doi-asserted-by":"crossref","first-page":"e184","DOI":"10.1038\/cddis.2011.67","volume":"2","author":"A. Pujals","year":"2011","unstructured":"Pujals, A., Renouf, B., Robert, A., Chelouah, S., Hollville, E., Wiels, J., 2011. Treatment with a BH3 mimetic overcomes the resistance of latency III EBV(+) cells to p53-mediated apoptosis. Cell Death Dis., 2(7):e184. [doi:10.1038\/cddis.2011.67]","journal-title":"Cell Death Dis."},{"issue":"5","key":"3347_CR82","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1038\/sj.cdd.4400998","volume":"9","author":"H. Puthalakath","year":"2002","unstructured":"Puthalakath, H., Strasser, A., 2002. Keeping killers on a tight leash: transcriptional and post-translational control of the pro-apoptotic activity of BH3-only proteins. Cell Death Differ., 9(5):505\u2013512. [doi:10.1038\/sj.cdd.4400998]","journal-title":"Cell Death Differ."},{"issue":"5303","key":"3347_CR83","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1126\/science.275.5302.967","volume":"275","author":"N. Rampino","year":"1997","unstructured":"Rampino, N., Yamamoto, H., Ionov, Y., Li, Y., Sawai, H., Reed, J.C., Perucho, M., 1997. Somatic frame shift mutations in the BAX gene in colon cancers of the microsatellite mutator phenotype. Science, 275(5303):967\u2013969. [doi:10.1126\/science.275.5302.967]","journal-title":"Science"},{"key":"3347_CR84","unstructured":"Rickinson, A.B., Kieff, E., 2007. Epstein-Barr virus. J. Virol., 2655\u20132700."},{"key":"3347_CR85","first-page":"2655","volume-title":"Fields of virology","author":"A.B. Rickinson","year":"2007","unstructured":"Rickinson, A.B., Kieff, E., 2007. Epstein-Barr Virus. In: Knipe, D.M., Howley, P.M., (Eds.), Fields of virology. Lippincott Williams & Wilkins, Philadelphia, PA, p.2655\u20132700"},{"issue":"11","key":"3347_CR86","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1038\/nrm1496","volume":"5","author":"S.J. Riedl","year":"2004","unstructured":"Riedl, S.J., Shi, Y., 2004. Molecular mechanisms of caspase regulation during apoptosis. Nat. Rev. Mol. Cell. Biol., 5(11):897\u2013907. [doi:10.1038\/nrm1496]","journal-title":"Nat. Rev. Mol. Cell. Biol."},{"issue":"9","key":"3347_CR87","doi-asserted-by":"crossref","first-page":"5602","DOI":"10.1128\/JVI.68.9.5602-5612.1994","volume":"68","author":"M. Rowe","year":"1994","unstructured":"Rowe, M., Peng-Pilon, M., Huen, D.S., Hardy, R., Croom-Carter, D., Lundgren, E., Rickinson, A.B., 1994. Up-regulation of bcl-2 by the Epstein-Barr virus latent membrane protein LMP1: a B-cell-specific response that is delayed relative to NF-\u03baB activation and to induction of cell surface markers. J. Virol., 68(9):5602\u20135612.","journal-title":"J. Virol."},{"issue":"6","key":"3347_CR88","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1053\/ajot.2001.28071","volume":"22","author":"S. Sarac","year":"2001","unstructured":"Sarac, S., Akyol, M.U., Kanbur, B., Poyraz, A., Akyol, G., Yilmaz, T., Sungur, A., 2001. Bcl-2 and LMP1 expression in nasopharyngeal carcinomas. Am. J. Otolaryng., 22(6): 377\u2013382. [doi:10.1053\/ajot.2001.28071]","journal-title":"Am. J. Otolaryng."},{"issue":"22","key":"3347_CR89","doi-asserted-by":"crossref","first-page":"10681","DOI":"10.1128\/JVI.74.22.10681-10689.2000","volume":"74","author":"F. Scholle","year":"2000","unstructured":"Scholle, F., Bendt, K.M., Raab-Traub, N., 2000. Epstein-Barr virus LMP2A transforms epithelial cells, inhibits cell differentiation, and activates Akt. J. Virol., 74(22): 10681\u201310689. [doi:10.1128\/JVI.74.22.10681-10689.2000]","journal-title":"J. Virol."},{"issue":"10","key":"3347_CR90","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1038\/sj.onc.1204217","volume":"20","author":"W. Sheng","year":"2001","unstructured":"Sheng, W., Decaussin, G., Sumner, S., Ooka, T., 2001. N-terminal domain of BARF1 gene encoded by Epstein-Barr virus is essential for malignant transformation of rodent fibroblasts and activation of BCL-2. Oncogene, 20(10):1176\u20131185. [doi:10.1038\/sj.onc.1204217]","journal-title":"Oncogene"},{"issue":"6","key":"3347_CR91","doi-asserted-by":"crossref","first-page":"3859","DOI":"10.1128\/JVI.77.6.3859-3865.2003","volume":"77","author":"W. Sheng","year":"2003","unstructured":"Sheng, W., Decaussin, G., Ligout, A., Takada, K., Ooka, T., 2003. Malignant transformation of Epstein-Barr virus-negative akata cells by introduction of the BARF1 gene carried by Epstein-Barr virus. J. Virol., 77(6):3859\u20133865. [doi:10.1128\/JVI.77.6.3859-3865.2003]","journal-title":"J. Virol."},{"issue":"8","key":"3347_CR92","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1099\/vir.0.19112-0","volume":"84","author":"A.J. Sinclair","year":"2003","unstructured":"Sinclair, A.J., 2003. bZIP proteins of human gammaherpesviruses. J. Gen. Virol., 84(8):1941\u20131949. [doi:10.1099\/vir.0.19112-0]","journal-title":"J. Gen. Virol."},{"key":"3347_CR93","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2011\/829525","volume":"2011","author":"L.C. Spender","year":"2011","unstructured":"Spender, L.C., Inman, G.J., 2011. Inhibition of germinal center apoptotic programmes by Epstein-Barr virus. Adv. Hematol., 2011:1\u201310. [doi:10.1155\/2011\/829525]","journal-title":"Adv. Hematol."},{"issue":"5","key":"3347_CR94","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1111\/j.1600-0609.2008.01044.x","volume":"80","author":"P. Srimatkandada","year":"2008","unstructured":"Srimatkandada, P., Loomis, R., Carbone, R., Srimatkandada, S., Lacy, J., 2008. Combined proteasome and Bcl-2 inhibition stimulates apoptosis and inhibits growth in EBV-transformed lymphocytes: a potential therapeutic approach to EBV-associated lymphoproliferative diseases. Eur. J. Haematol., 80(5):407\u2013418. [doi:10.1111\/j.1600-0609.2008.01044.x]","journal-title":"Eur. J. Haematol."},{"issue":"2","key":"3347_CR95","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1038\/sj.leu.2403241","volume":"18","author":"L.S. Steelman","year":"2004","unstructured":"Steelman, L.S., Pohnert, S.C., Shelton, J.G., Franklin, R.A., Bertrand, F.E., McCubrey, J.A., 2004. JAK\/STAT, Raf\/MEK\/ERK, PI3K\/Akt and BCR-ABL in cell cycle progression and leukemogenesis. Leukemia, 18(2):189\u2013218. [doi:10.1038\/sj.leu.2403241]","journal-title":"Leukemia"},{"issue":"5","key":"3347_CR96","doi-asserted-by":"crossref","first-page":"4015","DOI":"10.1128\/JVI.72.5.4015-4021.1998","volume":"72","author":"L.D. Strockbine","year":"1998","unstructured":"Strockbine, L.D., Cohen, J.I., Farrah, T., Lyman, S.D., Wagener, F., DuBose, R.F., Armitage, R.J., Spriggs, M.K., 1998. The Epstein-Barr virus BARF1 gene encodes a novel, soluble colony-stimulating factor-1 receptor. J. Virol., 72(5):4015\u20134021.","journal-title":"J. Virol."},{"issue":"6","key":"3347_CR97","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1038\/nrg2341","volume":"9","author":"M.M. Suzuki","year":"2008","unstructured":"Suzuki, M.M., Bird, A., 2008. DNA methylation landscapes: provocative insights from epigenomics. Nat. Rev. Genet., 9(6):465\u2013476. [doi:10.1038\/nrg2341]","journal-title":"Nat. Rev. Genet."},{"issue":"9","key":"3347_CR98","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1099\/vir.0.021444-0","volume":"91","author":"M. Swanson-Mungerson","year":"2010","unstructured":"Swanson-Mungerson, M., Bultema, R., Longnecker, R., 2010. Epstein-Barr virus LMP2A imposes sensitivity to apoptosis. J. Gen. Virol., 91(9):2197\u20132202. [doi:10.1099\/vir.0. 021444-0]","journal-title":"J. Gen. Virol."},{"issue":"7","key":"3347_CR99","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1007\/BF01240123","volume":"123","author":"Y. Takano","year":"1997","unstructured":"Takano, Y., Saegusa, M., Masuda, M., Mikami, T., Okayasu, I., 1997. Apoptosis, proliferative activity and Bcl-2 expression in Epstein-Barr-virus-positive non-Hodgkin\u2019s lymphoma. J. Cancer Res. Clin., 123(7):395\u2013401. [doi:10.1007\/BF01240123]","journal-title":"J. Cancer Res. Clin."},{"issue":"8","key":"3347_CR100","first-page":"1707","volume":"12","author":"P. Theodorakis","year":"1996","unstructured":"Theodorakis, P., D\u2019sa-Eipper, C., Subramanian, T., Chinnadurai, G., 1996. Unmasking of a proliferation-restraining activity of the anti-apoptosis protein EBV BHRF. Oncogene, 12(8):1707\u20131713.","journal-title":"Oncogene"},{"issue":"13","key":"3347_CR101","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1056\/NEJMra032015","volume":"350","author":"D.A. Thorley-Lawson","year":"2004","unstructured":"Thorley-Lawson, D.A., Gross, A., 2004. Persistence of the Epstein-Barr virus and the origins of associated lymphomas. N. Engl. J. Med., 350(13):1328\u20131337. [doi:10.1056\/NEJMra032015]","journal-title":"N. Engl. J. Med."},{"issue":"4","key":"3347_CR102","doi-asserted-by":"crossref","first-page":"2014","DOI":"10.1128\/JVI.67.4.2014-2025.1993","volume":"67","author":"B. Tomkinson","year":"1993","unstructured":"Tomkinson, B., Robertson, E., Kieff, E., 1993. Epstein-Barr virus nuclear proteins EBNA-3A and EBNA-3C are essential for B-lymphocyte growth transformation. J. Virol., 67(4):2014\u20132025.","journal-title":"J. Virol."},{"issue":"18","key":"3347_CR103","doi-asserted-by":"crossref","first-page":"4403","DOI":"10.1182\/blood-2008-08-173310","volume":"113","author":"M. Vogler","year":"2009","unstructured":"Vogler, M., Butterworth, M., Majid, A., Walewska, R.J., Sun, X.M., Dyer, M.J.S., Cohen, G.M., 2009. Concurrent up-regulation of BCL-XL and BCL2A1 induces approximately 1000-fold resistance to ABT-737 in chronic lymphocytic leukemia. Blood, 113(18):4403\u20134413. [doi:10.1182\/blood-2008-08-173310]","journal-title":"Blood"},{"issue":"10","key":"3347_CR104","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1007\/s001090100251","volume":"79","author":"V. Wachek","year":"2001","unstructured":"Wachek, V., Heere-Ress, E., Halaschek-Wiener, J., Lucas, T., Meyer, H., Eichler, H.G., Jansen, B., 2001. Bcl-2 antisense oligonucleotides chemosensitize human gastric cancer in a SCID mouse xenotransplantation model. J. Mol. Med., 79(10):587\u2013593. [doi:10.1007\/s001090100251]","journal-title":"J. Mol. Med."},{"key":"3347_CR105","first-page":"4610","volume":"56","author":"S. Wang","year":"1996","unstructured":"Wang, S., Rowe, M., Lundgren, E., 1996. Expression of the Epstein Barr virus transforming protein LMP1 causes a rapid and transient stimulation of the Bcl-2 homologue Mcl-1 levels in B-cell lines. Cancer Res., 56:4610\u20134613.","journal-title":"Cancer Res."},{"issue":"9","key":"3347_CR106","doi-asserted-by":"crossref","first-page":"1812","DOI":"10.1200\/JCO.2000.18.9.1812","volume":"18","author":"J.S. Waters","year":"2000","unstructured":"Waters, J.S., Webb, A., Cunningham, D., Clarke, P.A., Raynaud, F., di Stefano, F., Cotter, F.E., 2000. Phase I clinical and pharmacokinetic study of bcl-2 antisense oligonucleotide therapy in patients with non-Hodgkin\u2019s lymphoma. J. Clin. Oncol., 18(9):1812\u20131823.","journal-title":"J. Clin. Oncol."},{"issue":"5517","key":"3347_CR107","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1126\/science.1059108","volume":"292","author":"M.C. Wei","year":"2001","unstructured":"Wei, M.C., Zong, W.X., Cheng, E.H., Lindsten, T., Panoutsakopoulou, V., Ross, A.J., Roth, K.A., MacGregor, G.R., Thompson, C.B., Korsmeyer, S.J., 2001. Pro-apoptotic BAX and BAK: a requisite gateway to mitochondrial dysfunction and death. Science, 292(5517):727\u2013730. [doi:10.1126\/science.1059108]","journal-title":"Science"},{"issue":"1","key":"3347_CR108","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1101\/gad.10.1.1","volume":"10","author":"E. White","year":"1996","unstructured":"White, E., 1996. Life, death, and the pursuit of apoptosis. Gen. Dev., 10(1):1\u201315. [doi:10.1101\/gad.10.1.1]","journal-title":"Gen. Dev."},{"issue":"2","key":"3347_CR109","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1002\/mc.20133","volume":"44","author":"H.L. Wong","year":"2005","unstructured":"Wong, H.L., Wang, X., Chang, R.C., Jin, D.Y., Feng, H., Wang, Q., Lo, K.W., Huang, D.P., Yuen, P.W., Takada, K., et al., 2005. Stable expression of EBERs in immortalized nasopharyngeal epithelial cells confers resistance to apoptotic stress. Mol. Carcinogen., 44(2):92\u2013101. [doi:10.1002\/mc.20133]","journal-title":"Mol. Carcinogen."},{"issue":"5303","key":"3347_CR110","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1126\/science.275.5303.1126","volume":"275","author":"D. Wu","year":"1997","unstructured":"Wu, D., Wallen, H.D., Nunez, G., 1997. Interaction and regulation of subcellular localization of CED-4 by CED-9. Science, 275(5303):1126\u20131129. [doi:10.1126\/science.275.5303.1126]","journal-title":"Science"},{"issue":"7","key":"3347_CR111","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1054\/bjoc.2000.1687","volume":"84","author":"Z.G. Xu","year":"2001","unstructured":"Xu, Z.G., Iwatsuki, K., Oyama, N., Ohtsuka, M., Satoh, M., Kikuchi, S., Akiba, H., Kaneko, F., 2001. The latency pattern of Epstein-Barr virus infection and viral IL-10 expression in cutaneous natural killer\/T cell lymphomas. Br. J. Cancer, 84(7):920\u2013925. [doi:10.1054\/bjoc.2000.1687]","journal-title":"Br. J. Cancer"},{"issue":"27","key":"3347_CR112","doi-asserted-by":"crossref","first-page":"28367","DOI":"10.1074\/jbc.M313526200","volume":"279","author":"A.G. Yakovlev","year":"2004","unstructured":"Yakovlev, A.G., Giovanni, S.D., Wang, G., Liu, W., 2004. BOK and NOXA are essential mediators of p53-dependentapoptosis. J. Biol. Chem., 279(27):28367\u201328374. [doi:10.1074\/jbc.M313526200]","journal-title":"J. Biol. Chem."},{"issue":"6617","key":"3347_CR113","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1038\/385637a0","volume":"385","author":"C. Yin","year":"1997","unstructured":"Yin, C., Knudson, C.M., Korsmeyer, S.J., van Dyke., T., 1997. Bax suppresses tumorigenesis and stimulates apoptosis in vivo. Nature, 385(6617):637\u2013640. [doi:10.1038\/385637a0]","journal-title":"Nature"},{"issue":"3","key":"3347_CR114","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/S1097-2765(01)00213-1","volume":"7","author":"J. Yu","year":"2001","unstructured":"Yu, J., Zhang, L., Hwang, P.M., Kinzler, K.W., Vogelstein, B., 2001. PUMA induces the rapid apoptosis of colorectal cancer cells. Mol. Cell, 7(3):673\u2013682. [doi:10.1016\/S1097-2765(01)00213-1]","journal-title":"Mol. Cell"},{"issue":"299","key":"3347_CR115","first-page":"1","volume":"9","author":"C.Z. Zhang","year":"2010","unstructured":"Zhang, C.Z., Zhang, J.X., Zhang, L.A., Shi, Z.D., Han, L., Jia, Z.F., Yang, W.D., Wang, G.X., Jiang, T., You, Y.P., et al., 2010. MiR-221 and miR-222 target PUMA to induce cell survival in glioblastoma. Mol. Cancer, 9(299):1\u20139. [doi:10.1186\/1476-4598-9-229]","journal-title":"Mol. Cancer"},{"issue":"6","key":"3347_CR116","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1006\/scbi.2001.0409","volume":"11","author":"U. Zimber-Strobl","year":"2001","unstructured":"Zimber-Strobl, U., Strobl, L.J., 2001. EBNA2 and Notch signaling in Epstein-Barr virus mediated immortalization of B lymphocytes. Semin. Cancer Biol., 11(6):423\u2013434. [doi:10.1006\/scbi.2001.0409]","journal-title":"Semin. Cancer Biol."},{"issue":"8","key":"3347_CR117","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1038\/sj.cdd.4401987","volume":"13","author":"S. Zinkel","year":"2006","unstructured":"Zinkel, S., Gross, A., Yang, E., 2006. BCL2 family in DNA damage and cell cycle control. Cell Death Differ., 13(8):1351\u20131359. [doi:10.1038\/sj.cdd.4401987]","journal-title":"Cell Death Differ."},{"issue":"12","key":"3347_CR118","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1101\/gad.897601","volume":"15","author":"W.X. Zong","year":"2001","unstructured":"Zong, W.X., Lindsten, T., Ross, A.J., MacGregor, G.R., Thompson, C.B., 2001. BH3-only proteins that bind pro-survival Bcl-2 family members fail to induce apoptosis in the absence of Bax and Bak. Gene Dev., 15(12):1481\u20131486. [doi:10.1101\/gad.897601]","journal-title":"Gene Dev."},{"issue":"3","key":"3347_CR119","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/S0092-8674(00)80501-2","volume":"90","author":"H. Zou","year":"1997","unstructured":"Zou, H., Henzel, W.J., Liu, X., Lutschg, A., Wang, X., 1997. Apaf-1, a human protein homologous to C. elegans CED-4, participates in cytochrome c-dependent activation of caspase-3. Cell, 90(3):405\u2013413. [doi:10.1016\/S0092-8674(00)80501-2]","journal-title":"Cell"},{"issue":"12","key":"3347_CR120","doi-asserted-by":"crossref","first-page":"e1002455","DOI":"10.1371\/journal.ppat.1002455","volume":"7","author":"J. Zuo","year":"2011","unstructured":"Zuo, J., Thomas, W.A., Haigh, T.A., Fitzsimmons, L., Long, H.M., Hislop, A.D., Taylor, G.S., Rowe, M., 2011. Epstein-Barr virus evades CD4+ T cell responses in lytic cycle through BZLF1-mediated down-regulation of CD74 and the cooperation of vBcl-2. PLoS Pathog., 7(12):e1002455. [doi:10.1371\/journal.ppat.1002455]","journal-title":"PLoS Pathog."}],"container-title":["Journal of Zhejiang University SCIENCE B"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1631\/jzus.B1200189.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1631\/jzus.B1200189\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1631\/jzus.B1200189","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,20]],"date-time":"2020-07-20T02:44:48Z","timestamp":1595213088000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1631\/jzus.B1200189"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,1]]},"references-count":120,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,1]]}},"alternative-id":["3347"],"URL":"https:\/\/doi.org\/10.1631\/jzus.b1200189","relation":{},"ISSN":["1673-1581","1862-1783"],"issn-type":[{"value":"1673-1581","type":"print"},{"value":"1862-1783","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,1]]}}}